Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Elon Musk’s Neuralink expects to start human trials of wireless brain chip in 6 months

Published 01/12/2022, 09:40 pm
Updated 01/12/2022, 10:30 pm
© Reuters.  Elon Musk’s Neuralink expects to start human trials of wireless brain chip in 6 months
RSTP
-

Elon Musk’s Neuralink Corp expects to start inserting its wireless brain chip into human patients within six months, the US-based company said at an event yesterday.

Neuralink is developing a brain chip implant that it says could enable disabled patients to move and communicate again, which it demonstrated with a video of a monkey typing on a keyboard to order snacks using 'telepathic typing' with the chip communicating messages from its brain to a computer.

It needs approval from the US Food and Drug Administration (FDA) before it can start clinical trials on people.

Earlier this year, the company was forced to admit it had to euthanise eight animals as it responded to a complaint filed to the FDA by a pressure group of US physicians over claims it had "mutilated" the brains of several laboratory-kept monkeys.

"We want to be extremely careful and certain that it will work well before putting a device into a human," Musk told the event.

Musk, one of Neuralink’s founders, also revealed that the chip will seek to restore vision.

"Even if someone has never had vision, ever, like they were born blind, we believe we can still restore vision," he said.

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.